PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11181900-6	2001	When MMP-9 expression was stimulated by treatment with phorbol esters or tumor necrosis factor-alpha, lacidipine was able to inhibit this enhanced gelatinolytic capacity up to 50 and 60%, respectively.	lacidipine	102-112	tumor necrosis factor	Homo sapiens	73-100	
9488215-3	1997	In this study we evaluated the extent to which lacidipine, a calcium antagonist with antioxidant properties, affects the expression of intercellular cell adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin on human umbilical vein endothelial cells, induced by different pro-oxidant signals such as oxidized low density lipoprotein (LDL) and tumor necrosis factor-alpha (TNF-alpha).	lacidipine	47-57	tumor necrosis factor	Homo sapiens	377-404	
9488215-3	1997	In this study we evaluated the extent to which lacidipine, a calcium antagonist with antioxidant properties, affects the expression of intercellular cell adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin on human umbilical vein endothelial cells, induced by different pro-oxidant signals such as oxidized low density lipoprotein (LDL) and tumor necrosis factor-alpha (TNF-alpha).	lacidipine	47-57	tumor necrosis factor	Homo sapiens	406-415	
9488215-8	1997	The addition of lacidipine to human umbilical vein endothelial cells significantly reduced the expression of ICAM-1, VCAM-1 and E-selectin induced by TNF-alpha alone or with oxidized LDL (P < 0.001).	lacidipine	16-26	tumor necrosis factor	Homo sapiens	150-159	
30521476-7	2018	RESULTS: During the course of combined antihypertensive therapy with lacidipine and candesartan, a significant reduction in i-NOS activity, TNF-alpha to its type I soluble receptor ratio (TNF- alpha/sTNF-alphaRI), and oxidative stress marker - 8-iso-PgF2alpha has been observed.	lacidipine	69-79	tumor necrosis factor	Homo sapiens	140-149	
30521476-7	2018	RESULTS: During the course of combined antihypertensive therapy with lacidipine and candesartan, a significant reduction in i-NOS activity, TNF-alpha to its type I soluble receptor ratio (TNF- alpha/sTNF-alphaRI), and oxidative stress marker - 8-iso-PgF2alpha has been observed.	lacidipine	69-79	tumor necrosis factor	Homo sapiens	188-198